课题基金 / 基金详情

Viral determinants of hepatitis C virus resistance to interferon and their relevance for broad resistance to HCV specific antivirals.

Viral determinants of hepatitis C virus resistance to interferon and their relevance for broad resistance to HCV specific antivirals.
丙型肝炎病毒对干扰素耐药的病毒决定因素及其与丙型肝炎特异性抗病毒药物广泛耐药的相关性。
批准号:
410921131
负责人:
Dr. Julie Sheldon
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2022-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
HCV triggers type I and type III IFN production in the liver as well as massive induction of ISG, however, the virus is able to establish chronicity in most patients, this is most likely linked to HCV’s active evasion from IFN-mediated innate immunity and/or IFN-triggered effector mechanisms. We have recently developed a cell culture produced HCV (HCVcc) able to grow at high titres in the presence of interferon alpha and based on our previous results that show an increase in PKR- and EIF2alpha- phosphorylation and in turn an increase in host protein shut down, we hypothesize that viral adaptive changes may down-regulate HCV-dependent induction of interferon stimulated genes which in turn confers increased viral resistance. We aim in this project identify individual viral adaptive changes that confer increased antiviral resistance, investigate the impact of these adaptive changes on PKR phosphorylation and the role of increased PKR phosphorylation for antiviral resistance and finally investigate the impact of adaptive changes on IFN innate immune signalling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金